Projects per year
Fingerprint
Dive into the research topics where Francisco Espinoza is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Rol de la metil histona transferasa WHSC1 en la patogenia de la Osteoartritis
12/08/13 → 29/11/14
Project: Research
Research output
-
Association between chronic periodontitis and rheumatoid arthritis. A systematic review
Wen, S., Beltrán, V., Chaparro, A., Espinoza, F. & Riedemann, J. P., 1 Jan 2019, In: Revista Medica de Chile. 147, 6, p. 762-775 14 p.Research output: Contribution to journal › Article › peer-review
-
Mesenchymal stem cells improve rheumatoid arthritis progression by controlling memory T cell response
Luque-Campos, N., Contreras-López, R. A., Paredes-Martínez, M. J., Torres, M. J., Bahraoui, S., Wei, M., Espinoza, F., Djouad, F., Elizondo-Vega, R. J. & Luz-Crawford, P., 1 Jan 2019, In: Frontiers in Immunology. 10, MARResearch output: Contribution to journal › Scientific review › peer-review
-
METHOD FOR OBTAINING A COMPOSITION CONTAINING A SPECIFIC POPULATION OF UMBILICAL CORD MESENCHYMAL CELLS AND USES THEREOF
Maroun, K., Figueroa, F., Espinoza, F., Bartolucci, J., Castro, D., Montoya, P., González, P. & Cuenca, J., 21 Mar 2019, IPC No. C12N 5/ 0775 A I, Patent No. WO2019051623, Priority date 16 Sep 2017, Priority No. CL20170002357Research output: Patent
-
Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial
Matas, J., Orrego, M., Amenabar, D., Infante, C., Tapia-Limonchi, R., Cadiz, M. I., Alcayaga-Miranda, F., González, P. L., Muse, E., Khoury, M., Figueroa, F. E. & Espinoza, F., 1 Mar 2019, In: Stem cells translational medicine. 8, 3, p. 215-224 10 p.Research output: Contribution to journal › Article › peer-review
-
Implementation of an early rheumatoid athritis unit for the early recognition and treatment of the disease
Espinoza, F., Monckeberg, G., Hassi, I., Queirolo, A., Chicao, F., Sandoval, X., Jorquera, E. & Badilla, A., 1 Jan 2018, In: Revista Medica de Chile. 146, 1, p. 39-45 7 p.Research output: Contribution to journal › Article › peer-review
Press / Media
-
A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1)
1/02/19
1 item of Media coverage
Press/Media
-
Clinical Trial: Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis
28/01/19
1 item of Media coverage
Press/Media
-
Osteoarthritis Stem Cell Therapy Success in Phase I and II Trials
Maroun Khoury & Francisco Espinoza
11/01/19
1 item of Media coverage
Press/Media
-
A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis
2/10/18
1 item of Media coverage
Press/Media